Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model. - Wikidata - wikimedia - TriplyDB

Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.

Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.

http://www.wikidata.org/entity/Q34575393

about

Interferon protects mice against inhalation anthrax Sampling port for real-time analysis of bioaerosol in whole body exposure system for animal aerosol model development Identification of novel and cross-species seroreactive proteins from Bacillus anthracis using a ligation-independent cloning-based, SOS-inducible expression system Novel and unique diagnostic biomarkers for Bacillus anthracis infection.In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection model In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis.Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.Airway epithelial NF-κB activation promotes Mycoplasma pneumoniae clearance in mice.Characterization of Bacillus anthracis persistence in vivo.Development of an aerosol model of Cryptococcus reveals humidity as an important factor affecting the viability of Cryptococcus during aerosolization.Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure.The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected Host Daptomycin exerts rapid bactericidal activity against Bacillus anthracis without disrupting membrane integrity Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model.Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.Natural History of Francisella tularensis in Aerosol-Challenged BALB/c Mice.Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax Bacillus anthracis Spore Surface Protein BclA Mediates Complement Factor H Binding to Spores and Promotes Spore Persistence Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.Isolation and characterization of superdormant spores of Bacillus species Superdormant spores of Bacillus species have elevated wet-heat resistance and temperature requirements for heat activation.Hollow-fiber pharmacodynamic studies and mathematical modeling to predict the efficacy of amoxicillin for anthrax postexposure prophylaxis in pregnant women and children.Pathology of inhalational anthrax animal models.Antimicrobials for bacterial bioterrorism agents.The fluorocycline TP-271 is efficacious in models of aerosolized Bacillus anthracis infection in BALB/c mice and cynomolgus macaques.Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages.Evaluation of Inhaled Versus Deposited Dose Using the Exponential Dose-Response Model for Inhalational Anthrax in Nonhuman Primate, Rabbit, and Guinea Pig.Antibiotics cure anthrax in animal models.Levels of germination proteins in dormant and superdormant spores of Bacillus subtilis.Is 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for Bacillus anthracis?Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.Treating Anthrax-Induced Meningitis in Rabbits.

P2860

Q28384715-7F187A96-08B2-4BBC-A819-ECCD46B2D61C Q28385759-BF386514-E968-4EC8-8D49-7CD1466B280B Q28388913-9E667BF4-B916-413E-B403-C01529620B7C Q30157179-29CC29D4-CD42-407C-BEDB-25BB85341C5C Q33576071-5D42A056-579B-47D7-AFC8-B1428562D3D2 Q33601803-F2DDDCDD-FABA-441D-9EFF-BB98CE00F223 Q33676316-542BABEF-224F-40DD-BCF4-69D903CCB662 Q33826432-96A9EF12-F990-47B9-ADDD-7F21CA557A79 Q34150994-77562A67-A498-4C11-96AA-658C8D1039F8 Q34368520-A2F2D747-B2C7-4861-B6AE-296E463C664B Q34534925-5072B246-1EA6-4734-8B7F-905F4445C604 Q34764384-95E2C8DF-CC91-408B-B798-FFCE1264C445 Q34874531-4B567307-2C16-46DB-9954-084D0EC0F884 Q35806278-47F0A7B9-B85D-43FF-A150-87A84DEE061D Q36122915-B2372DC4-2FC9-43A0-8995-A3BD32D4BF13 Q36294717-E5A82A7D-F927-4049-90D0-6FCB90022657 Q36295305-B07F6B53-EE30-4005-85D5-1D7875DFE32B Q36313211-7C511569-2CA7-4D3B-B82E-7BB4BEF53E6E Q36523135-13CA49CB-FC03-4CFA-9307-9B925EA11ED7 Q36644836-AF885D74-223E-4F6A-BFE0-B9469E4AB280 Q36870766-DADA7616-9BE6-4FD9-A8D3-C49586E6442A Q37008156-31BBE3E5-0E14-4E9D-814F-9DBA074E41F9 Q37033041-3B1B8DD3-644F-4A14-B2A4-413191749B46 Q37110843-03EC7410-351B-40E5-B4F3-0BE03809E4C8 Q37333254-56122FC6-C8DC-432E-9CC3-01A091380D4E Q37335844-80F6D811-DCAD-49AB-B419-13FA271DC631 Q37775428-BEDBEF9E-43F3-4427-970F-E495495686E9 Q37894696-FD2949B9-BA07-48F1-B3F1-1E84F3C0329C Q40103244-30EF1A74-CB6C-4713-A629-489F635C560D Q40112607-89B0AA86-71E1-4AF0-9DE4-68E9B132FA21 Q41643460-33C8371F-0393-44F9-B1E9-9D1A74BF97C0 Q41890173-C1802AD6-7771-440D-826E-CE5B3BF00A33 Q42081790-5E57F4F3-7C8F-4B39-A770-AD9D0B6ED0D1 Q43251072-9DB6A0C9-3615-4A99-A115-5A28F56A7071 Q47976373-026B36A5-BDA5-47BC-B265-F0D6F51986BF Q52584720-E1778E2B-8E27-44FC-B05E-E6B9A2731237

P2860

Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.

http://www.wikidata.org/entity/Q34575393

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Determination of antibiotic ef ...... mouse aerosol challenge model.

@ast

Determination of antibiotic ef ...... mouse aerosol challenge model.

@en

Determination of antibiotic ef ...... mouse aerosol challenge model.

@nl

type

label

Determination of antibiotic ef ...... mouse aerosol challenge model.

@ast

Determination of antibiotic ef ...... mouse aerosol challenge model.

@en

Determination of antibiotic ef ...... mouse aerosol challenge model.

@nl

prefLabel

Determination of antibiotic ef ...... mouse aerosol challenge model.

@ast

Determination of antibiotic ef ...... mouse aerosol challenge model.

@en

Determination of antibiotic ef ...... mouse aerosol challenge model.

@nl

P1433

Q34575393-AC5D9E04-7A74-4A86-AB31-86B228556D4E

P1476

Q34575393-280CA9C7-2792-4AEE-9635-1B7C1178C541

P2093

Q34575393-04583E73-24F4-43FA-AE2A-A54F97793A4B

Q34575393-06801FD1-D00C-45FB-A32E-772F2595672E

Q34575393-2A161093-9211-40E4-BB53-225FB1105F74

Q34575393-313A5422-03DD-4CC7-A8B6-252ADD972C5E

Q34575393-7845A2B9-7576-434B-97A6-24C662B69A65

Q34575393-B41ED0F6-32B7-41AE-8928-C2D2D947CB2F

Q34575393-C9559467-E8C5-480B-8234-C90CE684E996

Q34575393-D27D0757-8143-46D4-BA50-1E043B07C3BA

Q34575393-E526FF96-2746-49CC-9743-A33FA7B4DA87

P2860

Q34575393-00D1893D-F614-4A36-861E-55B0C8810E63

Q34575393-03F43F58-824C-4166-9F1D-EBA25CA3DF6F

Q34575393-05C84F13-1E8F-4B5C-90F5-252EBF82844F

Q34575393-0F0D3F93-91C8-4E24-8517-3E4364F7AD38

Q34575393-155390EC-AF3F-40DB-AC7F-EF0FA941E9C7

Q34575393-1E88FFC8-B31E-482C-8CC7-37FBC540AD11

Q34575393-3BE74B8A-C21B-47C0-82DB-A83E76FF92BD

Q34575393-4BEE38FD-6637-4B46-87D6-CDE48B612472

Q34575393-5D639D2F-AD70-4B80-AEAE-0FEBB7151489

Q34575393-6EA5F65C-20AA-41DE-A855-7B97AF384C02

P304

Q34575393-21690DC4-4A65-4718-8800-830145BF026D

P31

Q34575393-C6959379-5B8B-4774-943D-76E3411E235B

P356

Q34575393-7B0DA21F-1C16-4C60-A40E-C3DC89B900F0

P407

Q34575393-07C663BF-112C-4849-8DC8-CB27F9D3B3EC

P433

Q34575393-BA8BE83B-78C5-471C-894F-1D5C8403D045

P478

Q34575393-5936AB16-92CD-4583-8236-263F4126A1F3

P577

Q34575393-3FF04B00-CE0B-4B08-928F-590582CBD12F

P5875

Q34575393-954B3208-F36D-4B35-BFB7-6495684219AC

P698

Q34575393-41425289-0EA9-45C0-8EF0-319D6BBC1C35

P921

Q34575393-BA3CB028-E9D6-4109-95D0-0C26F91FE7F2

P932

Q34575393-1A5310F2-D92D-4A9A-86B9-ECF64734F1F8

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Determination of antibiotic ef ...... mouse aerosol challenge model.

@en

P2093

Bruce E Ivins

http://www.w3.org/2001/XMLSchema#string

David Fritz

http://www.w3.org/2001/XMLSchema#string

Henry S Heine

http://www.w3.org/2001/XMLSchema#string

Jennifer Bassett

http://www.w3.org/2001/XMLSchema#string

Justin M Hartings

http://www.w3.org/2001/XMLSchema#string

Lynda Miller

http://www.w3.org/2001/XMLSchema#string

M Louise Pitt

http://www.w3.org/2001/XMLSchema#string

Sarah L Norris

http://www.w3.org/2001/XMLSchema#string

W Russell Byrne

http://www.w3.org/2001/XMLSchema#string

P2860

Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility

Anthrax as a biological weapon, 2002: updated recommendations for management

Anthrax: clinical features, pathogenesis, and potential biological warfare threat.

Anthrax spores make an essential contribution to vaccine efficacy

Antimicrobial therapy for bacillus anthracis-induced polymicrobial infection in (60)Co gamma-irradiated mice

Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs.

Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods

Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.

An ounce of prevention is a ton of work: mass antibiotic prophylaxis for anthrax, New York City, 2001.

Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.

P304

1373-1379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01050-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6508094

http://www.w3.org/2001/XMLSchema#string

P698

17296745

http://www.w3.org/2001/XMLSchema#string

P921

P932

1855446

http://www.w3.org/2001/XMLSchema#string